Marx K - Search Results

1

Navigating the online food environment: policy pathways for promoting food access, transparency, and healthy food choices online.

Greenthal E, Marx K, Friedman E, John S, Johnson J, LiPuma C, Nara D, Sorscher S, Gardner K, Musicus A. Greenthal E, et al. Among authors: marx k. Front Nutr. 2024 Oct 8;11:1473303. doi: 10.3389/fnut.2024.1473303. eCollection 2024. Front Nutr. 2024. PMID: 39439521 Free PMC article.

2

Greenthal E, Marx K, Grossman ER, Ruffin M, Lucas SA, Benjamin-Neelon SE. Greenthal E, et al. Among authors: marx k. Am J Health Promot. 2025 Jan;39(1):52-62. doi: 10.1177/08901171241271402. Epub 2024 Aug 14. Am J Health Promot. 2025. PMID: 39140236

3

Associations Between Nursing Students' Knowledge, Skills, and Attitudes and Participation in Experiential Learning on Care for People With Disabilities.

Ozkara San E, Marx KA, Robertiello G, Nahum JL, Hu J, Pasklinsky N, Latimer B. Ozkara San E, et al. Among authors: marx ka. Nurse Educ. 2024 Oct 25. doi: 10.1097/NNE.0000000000001761. Online ahead of print. Nurse Educ. 2024. PMID: 39453884

4

Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.

Solomon SD, McMurray JJV, Vaduganathan M, Claggett B, Jhund PS, Desai AS, Henderson AD, Lam CSP, Pitt B, Senni M, Shah SJ, Voors AA, Zannad F, Abidin IZ, Alcocer-Gamba MA, Atherton JJ, Bauersachs J, Chang-Sheng M, Chiang CE, Chioncel O, Chopra V, Comin-Colet J, Filippatos G, Fonseca C, Gajos G, Goland S, Goncalvesova E, Kang S, Katova T, Kosiborod MN, Latkovskis G, Lee AP, Linssen GCM, Llamas-Esperón G, Mareev V, Martinez FA, Melenovský V, Merkely B, Nodari S, Petrie MC, Saldarriaga CI, Saraiva JFK, Sato N, Schou M, Sharma K, Troughton R, Udell JA, Ukkonen H, Vardeny O, Verma S, von Lewinski D, Voronkov L, Yilmaz MB, Zieroth S, Lay-Flurrie J, van Gameren I, Amarante F, Kolkhof P, Viswanathan P; FINEARTS-HF Committees and Investigators. Solomon SD, et al. N Engl J Med. 2024 Oct 24;391(16):1475-1485. doi: 10.1056/NEJMoa2407107. Epub 2024 Sep 1. N Engl J Med. 2024. PMID: 39225278 Clinical Trial.

5

Metagenomic next-generation sequencing as a diagnostic tool in the clinical routine of an infectious diseases department: a retrospective cohort study.

Kalbitz S, Ermisch J, Kellner N, Nickel O, Borte S, Marx K, Lübbert C. Kalbitz S, et al. Among authors: marx k. Infection. 2024 Aug;52(4):1595-1600. doi: 10.1007/s15010-024-02300-2. Epub 2024 May 22. Infection. 2024. PMID: 38777941 Free PMC article.

6

Qualitative Analysis of Implementation Factors of an Embedded Caregiver Support Intervention into Adult Day Services.

Cotton QD, Albers E, Ingvalson S, Skalla E, Bailey D, Marx K, Anderson K, Dabelko-Schoeny H, Parker L, Gitlin LN, Gaugler JE. Cotton QD, et al. Among authors: marx k. J Alzheimers Dis. 2024;98(2):445-463. doi: 10.3233/JAD-230787. J Alzheimers Dis. 2024. PMID: 38461501

7

Dose-Dense Mini-Hyper-CVD, Inotuzumab Ozogamicin and Blinatumomab Achieves Rapid MRD-Negativity in Philadelphia Chromosome-Negative B-cell Acute Lymphoblastic Leukemia.

Short NJ, Jabbour E, Jamison T, Paul S, Cuglievan B, McCall D, Gibson A, Jain N, Haddad FG, Nasr LF, Marx KR, Rausch C, Savoy JM, Garris R, Ravandi F, Kantarjian H. Short NJ, et al. Among authors: marx kr. Clin Lymphoma Myeloma Leuk. 2024 Apr;24(4):e168-e173. doi: 10.1016/j.clml.2023.12.016. Epub 2023 Dec 30. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38212207

8

Correction: The biotoxin BMAA promotes dysfunction via distinct mechanisms in neuroblastoma and glioblastoma cells.

Burton B, Collins K, Brooks J, Marx K, Renner A, Wilcox K, Moore E, Osowski K, Riley J, Rowe J, Pawlus M. Burton B, et al. Among authors: marx k. PLoS One. 2024 Jan 2;19(1):e0296579. doi: 10.1371/journal.pone.0296579. eCollection 2024. PLoS One. 2024. PMID: 38165868 Free PMC article.

9

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial.

EMPA-KIDNEY Collaborative Group. EMPA-KIDNEY Collaborative Group. Lancet Diabetes Endocrinol. 2024 Jan;12(1):51-60. doi: 10.1016/S2213-8587(23)00322-4. Epub 2023 Dec 4. Lancet Diabetes Endocrinol. 2024. PMID: 38061372 Free article. Clinical Trial.

10

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial.

EMPA-KIDNEY Collaborative Group. EMPA-KIDNEY Collaborative Group. Lancet Diabetes Endocrinol. 2024 Jan;12(1):39-50. doi: 10.1016/S2213-8587(23)00321-2. Epub 2023 Dec 4. Lancet Diabetes Endocrinol. 2024. PMID: 38061371 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters